A Unique Case of a Pediatric Patient with Six Childhood Cancers in Association with a Germline TP53 Gene Pathogenic Variant

IF 2.3 3区医学 Q2 HEMATOLOGY Pediatric Blood & Cancer Pub Date : 2024-12-19 DOI:10.1002/pbc.31487

Shaelene Standing, David Malkin, Donna L. Johnston

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

一个独特的小儿患者病例：六种儿童癌症与种系 TP53 基因致病性变异有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pediatric Blood & Cancer 医学-小儿科

CiteScore

4.90

自引率

9.40%

发文量

546

审稿时长

1.5 months

期刊介绍： Pediatric Blood & Cancer publishes the highest quality manuscripts describing basic and clinical investigations of blood disorders and malignant diseases of childhood including diagnosis, treatment, epidemiology, etiology, biology, and molecular and clinical genetics of these diseases as they affect children, adolescents, and young adults. Pediatric Blood & Cancer will also include studies on such treatment options as hematopoietic stem cell transplantation, immunology, and gene therapy.

期刊最新文献

Comment on: "Delivering Care Consistent With the Psychosocial Standards: Provider Report From the iSTEPPP Study." Bridging the Gap Between Psychosocial Standards and Real-World Implementation in Pediatric Oncology. Comment on: Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long-Term Exposure While Maintaining Efficacy. A Ball Gown That Fits All. Correction to "Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study". Trajectory of Neurocognitive Functioning in Children Treated for Acute Lymphoblastic Leukemia (ALL): Dana-Farber Cancer Institute ALL Consortium Study 16-001. Machine Learning-Based Prediction Model for Delayed Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer: A Prospective Cohort Study.